Daniela Anne Braun1, Jennifer Ashley Lawson1, Heon Yung Gee2, Jan Halbritter3, Shirlee Shril1, Weizhen Tan1, Deborah Stein1, Ari J Wassner4, Michael A Ferguson1, Zoran Gucev5, Brittany Fisher1, Leslie Spaneas1, Jennifer Varner1, John A Sayer6, Danko Milosevic7, Michelle Baum1, Velibor Tasic5, Friedhelm Hildebrandt8. 1. Division of Nephrology, Department of Medicine and. 2. Division of Nephrology, Department of Medicine and Department of Pharmacology, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea; 3. Division of Nephrology, Department of Medicine and Division of Endocrinology/Nephrology, Department of Internal Medicine, University Clinic Leipzig, Leipzig, Germany; 4. Division of Endocrinology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; 5. Department of Pediatric Nephrology, Medical Faculty Skopje, University Children's Hospital, Skopje, Macedonia; 6. Institute of Genetic Medicine, International Centre for Life, Newcastle University, Newcastle upon Tyne, United Kingdom; 7. Department of Pediatric Nephrology, Dialysis and Transplantation, Clinical Hospital Center Zagreb, University of Zagreb Medical School, Zagreb, Croatia; and. 8. Division of Nephrology, Department of Medicine and Howard Hughes Medical Institute, Chevy Chase, Maryland friedhelm.hildebrandt@childrens.harvard.edu.
Abstract
BACKGROUND AND OBJECTIVES: Nephrolithiasis is a prevalent condition that affects 10%-15% of adults in their lifetime. It is associated with high morbidity due to colicky pain, the necessity for surgical intervention, and sometimes progression to CKD. In recent years, multiple monogenic causes of nephrolithiasis and nephrocalcinosis have been identified. However, the prevalence of each monogenic gene in a pediatric renal stone cohort has not yet been extensively studied. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: To determine the percentage of cases that can be explained molecularly by mutations in one of 30 known nephrolithiasis/nephrocalcinosis genes, we conducted a high-throughput exon sequencing analysis in an international cohort of 143 individuals <18 years of age, with nephrolithiasis (n=123) or isolated nephrocalcinosis (n=20). Over 7 months, all eligible individuals at three renal stone clinics in the United States and Europe were approached for study participation. RESULTS: We detected likely causative mutations in 14 of 30 analyzed genes, leading to a molecular diagnosis in 16.8% (24 of 143) of affected individuals; 12 of the 27 detected mutations were not previously described as disease causing (44.4%). We observed that in our cohort all individuals with infantile manifestation of nephrolithiasis or nephrocalcinosis had causative mutations in recessive rather than dominant monogenic genes. In individuals who manifested later in life, causative mutations in dominant genes were more frequent. CONCLUSIONS: We present the first exclusively pediatric cohort examined for monogenic causes of nephrolithiasis/nephrocalcinosis, and suggest that important therapeutic and preventative measures may result from mutational analysis in individuals with early manifestation of nephrolithiasis or nephrocalcinosis.
BACKGROUND AND OBJECTIVES:Nephrolithiasis is a prevalent condition that affects 10%-15% of adults in their lifetime. It is associated with high morbidity due to colicky pain, the necessity for surgical intervention, and sometimes progression to CKD. In recent years, multiple monogenic causes of nephrolithiasis and nephrocalcinosis have been identified. However, the prevalence of each monogenic gene in a pediatric renal stone cohort has not yet been extensively studied. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: To determine the percentage of cases that can be explained molecularly by mutations in one of 30 known nephrolithiasis/nephrocalcinosis genes, we conducted a high-throughput exon sequencing analysis in an international cohort of 143 individuals <18 years of age, with nephrolithiasis (n=123) or isolated nephrocalcinosis (n=20). Over 7 months, all eligible individuals at three renal stone clinics in the United States and Europe were approached for study participation. RESULTS: We detected likely causative mutations in 14 of 30 analyzed genes, leading to a molecular diagnosis in 16.8% (24 of 143) of affected individuals; 12 of the 27 detected mutations were not previously described as disease causing (44.4%). We observed that in our cohort all individuals with infantile manifestation of nephrolithiasis or nephrocalcinosis had causative mutations in recessive rather than dominant monogenic genes. In individuals who manifested later in life, causative mutations in dominant genes were more frequent. CONCLUSIONS: We present the first exclusively pediatric cohort examined for monogenic causes of nephrolithiasis/nephrocalcinosis, and suggest that important therapeutic and preventative measures may result from mutational analysis in individuals with early manifestation of nephrolithiasis or nephrocalcinosis.
Authors: L J Bruce; D L Cope; G K Jones; A E Schofield; M Burley; S Povey; R J Unwin; O Wrong; M J Tanner Journal: J Clin Invest Date: 1997-10-01 Impact factor: 14.808
Authors: S H Pearce; C Williamson; O Kifor; M Bai; M G Coulthard; M Davies; N Lewis-Barned; D McCredie; H Powell; P Kendall-Taylor; E M Brown; R V Thakker Journal: N Engl J Med Date: 1996-10-10 Impact factor: 91.245
Authors: F E Karet; K E Finberg; R D Nelson; A Nayir; H Mocan; S A Sanjad; J Rodriguez-Soriano; F Santos; C W Cremers; A Di Pietro; B I Hoffbrand; J Winiarski; A Bakkaloglu; S Ozen; R Dusunsel; P Goodyer; S A Hulton; D K Wu; A B Skvorak; C C Morton; M J Cunningham; V Jha; R P Lifton Journal: Nat Genet Date: 1999-01 Impact factor: 38.330
Authors: L Bisceglia; M J Calonge; L Dello Strologo; G Rizzoni; L de Sanctis; M Gallucci; E Beccia; X Testar; A Zorzano; X Estivill; L Zelante; M Palacin; P Gasparini; V Nunes Journal: Hum Genet Date: 1996-10 Impact factor: 4.132
Authors: M J Calonge; P Gasparini; J Chillarón; M Chillón; M Gallucci; F Rousaud; L Zelante; X Testar; B Dallapiccola; F Di Silverio Journal: Nat Genet Date: 1994-04 Impact factor: 38.330
Authors: Nina Mann; Daniela A Braun; Kassaundra Amann; Weizhen Tan; Shirlee Shril; Dervla M Connaughton; Makiko Nakayama; Ronen Schneider; Thomas M Kitzler; Amelie T van der Ven; Jing Chen; Hadas Ityel; Asaf Vivante; Amar J Majmundar; Ankana Daga; Jillian K Warejko; Svjetlana Lovric; Shazia Ashraf; Tilman Jobst-Schwan; Eugen Widmeier; Hannah Hugo; Shrikant M Mane; Leslie Spaneas; Michael J G Somers; Michael A Ferguson; Avram Z Traum; Deborah R Stein; Michelle A Baum; Ghaleb H Daouk; Richard P Lifton; Shannon Manzi; Khashayar Vakili; Heung Bae Kim; Nancy M Rodig; Friedhelm Hildebrandt Journal: J Am Soc Nephrol Date: 2019-01-17 Impact factor: 10.121